Historique
Périodique
Buprenorphine maintenance: office-based treatment with addiction clinic support
(Maintien à la buprénorphine : traitement ambulatoire avec le soutien d'un centre spécialisé)
Auteur(s) :
R. ORTNER ;
R. JAGSCH ;
S. D. SCHINDLER ;
A. PRIMORAC ;
G. FISCHER ;
GENERAL PRACTITIONER ADDICTION TEAM
Article en page(s) :
105-111
Refs biblio. :
29
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Thésaurus mots-clés
PRESCRIPTION MEDICALE
;
OPIACES
;
TRAITEMENT DE MAINTENANCE
;
BUPRENORPHINE
Thésaurus géographique
AUTRICHE
Note générale :
European Addiction Research, 2004, 10, (3), 105-111
Note de contenu :
fig. ; tabl.
Résumé :
ENGLISH :
Introduction: Buprenorphine has already been registered in 27 European countries for maintenance therapy in opioid-dependent patients. In our office-based prescription study we applied sublingual buprenorphine, initiating the treatment at the addiction clinic with subsequent treatment at the offices of general practitioners (GPs) to evaluate its efficacy and feasibility in two different treatment settings. Methods: Sixty opioid-dependent patients were studied for a period of 15 weeks. The first 3 weeks of treatment initiation took place at the addiction clinic, followed by 12 weeks of treatment by GPs. Mean outcome measures were retention rate and additional consumption of illicit substances in addition to the evaluation of whether buprenorphine can be prescribed successfully by GPs. Results: The retention rate was 57% (n = 34). No significant differences occurred between the treatment phases at the specialized addiction unit and the GPs' offices. During the 15-week period a significant improvement in well-being and a significant reduction in craving for heroin (p
ENGLISH :
Introduction: Buprenorphine has already been registered in 27 European countries for maintenance therapy in opioid-dependent patients. In our office-based prescription study we applied sublingual buprenorphine, initiating the treatment at the addiction clinic with subsequent treatment at the offices of general practitioners (GPs) to evaluate its efficacy and feasibility in two different treatment settings. Methods: Sixty opioid-dependent patients were studied for a period of 15 weeks. The first 3 weeks of treatment initiation took place at the addiction clinic, followed by 12 weeks of treatment by GPs. Mean outcome measures were retention rate and additional consumption of illicit substances in addition to the evaluation of whether buprenorphine can be prescribed successfully by GPs. Results: The retention rate was 57% (n = 34). No significant differences occurred between the treatment phases at the specialized addiction unit and the GPs' offices. During the 15-week period a significant improvement in well-being and a significant reduction in craving for heroin (p
Affiliation :
Dept Gen. Psychiat., Univ. Hosp. Vienna
Autriche. Austria.
Autriche. Austria.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |